Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HKT-500 in Knee Osteoarthritis Pain
NCT00792727Phase 3Completed
- Sponsor
- Hisamitsu Pharmaceutical Co., Inc.
- Start
- Sep 2007
- Primary completion
- Apr 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in osteoarthritis (OA) comparing Ketoprofen Patch with Placebo Patch (2 arms). Primary endpoint: Change from baseline of the WOMAC pain subscale score at 14 days. Started Sep 2007; status: completed.
02
Drugs
Ketofen
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT00792727.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00792727.